Muraki, Y <br/><br/>
Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010.  [electronic resource] 

 -  Infection  Apr 2013 
 - 415-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1439-0973 
<br/><br/><label>Standard No.: </label>10.1007/s15010-013-0440-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amikacin--therapeutic use<br/>Anti-Bacterial Agents--therapeutic use<br/>Ciprofloxacin--therapeutic use<br/>Drug Resistance, Multiple, Bacterial<br/>Drug Utilization--statistics & numerical data<br/>Drug Utilization Review--methods<br/>Hospitals--standards<br/>Humans<br/>Imipenem--therapeutic use<br/>Incidence<br/>Japan--epidemiology<br/>Meropenem<br/>Microbial Sensitivity Tests<br/>National Health Programs<br/>Pseudomonas Infections--drug therapy<br/>Pseudomonas aeruginosa--drug effects<br/>Retrospective Studies<br/>Surveys and Questionnaires<br/>Thienamycins--therapeutic use